Reimagining Professional Meetings: Another Lesson From COVID-19
Santa, Can You Hear Me?
Active Systemic Treatment of Pancreatic Cancer
By 2020, pancreatic cancer is expected to be the second most common cause of cancer-related death, exceeded only by lung cancer. During her presentation at the NCCN 22nd Annual Conference, Dr. Margaret Tempero offered an update on the current state of systemic treatment of pancreatic cancer, focusing on resectable/borderline resectable, locally advanced, and metastatic disease.